Chronic Pain
Study register · detail Meta-Analyse · Chronic Pain · 2017

Are cannabinoids an effective treatment for chronic non-cancer pain?

Unclear GRADE High 1 citations
Samplek = 32 Studien
Durationunclear
ControlPlacebo
EndpointPain intensity
Blindingunklar
DesignMeta-Analyse
Key finding

The evidence is very low, therefore it is unclear whether cannabinoids reduce pain in chronic non-cancer pain, but they are associated with significant adverse effects.

Summary

Systematic review + meta-analysis via Epistemonikos database on cannabinoids in chronic non-cancer pain; k=32 RCTs identified from 37 systematic reviews. GRADE analysis: unclear whether cannabinoids reduce pain — evidence quality very low (very low certainty). Significant adverse effects reported.

P
PopulationAdults with chronic non-cancer pain, pooled studies from 37 systematic reviews
I
InterventionCannabinoids (various substances/applications)
C
ControlPlacebo
O
OutcomeUnclear pain reduction with very low certainty of evidence (GRADE); significant adverse effects demonstrated
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size
Citations / year
Authors
Allende-Salazar R F, Rada G
DOI 10.5867/medwave.2017.6972
Design: Meta-Analyse
Share
Abstract
The use of cannabinoids has been proposed as an analgesic for different painful conditions, especially for chronic pain refractory to usual treatment. However, its real efficacy and safety remains controversial. We sought to determine whether cannabinoids are an effective treatment for chronic non-cancer pain. To answer this question, we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We identified 37 systematic reviews including 41 studies overall, of which 32 were randomized trials relevant for the question of interest. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis and generated a summary of findings table using the GRADE approach. We concluded it is not clear whether cannabinoids decrease pain in patients with chronic non-cancer pain because the certainty of available evidence is very low. On the other hand, they are associated with significant adverse effects.

The impediment to action advances action. — Marcus Aurelius